Abivax SA
ABVX.PA
| Exchange: | PA |
| Currency | Euro |
| ISIN: | FR0012333284 |
| Primary Ticker: | ABVX.PA |
| Fiscal Year End: | December |
| International Domestic: | International |
| Sector: | Healthcare |
| Industry: | Biotechnology |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France. |
| Address: | 7-11 boulevard Haussmann, Paris, France, 75009 |
| Website: | https://www.abivax.com |
| Full Time Employees: | 62 |
| Updated On: | 2024-11-03 |
Highlights
| Market Capitalization: | 597718144 |
| Market Capitalization Mln: | 597.71 |
| EBITDA: | -169872000 |
| Wall Street Target Price: | 29.8 |
| Book Value: | 2.01 |
| Earnings Share: | -3.43 |
| Most Recent Quarter: | 2024-06-30 |
| Operating Margin TTM: | -11.78 |
| Return On Assets TTM: | -0.46 |
| Return On Equity TTM: | -1.71 |
| Revenue TTM: | 9031000 |
| Revenue Per Share TTM: | 0.16 |
| Quarterly Revenue Growth YOY: | 2.01 |
| Gross Profit TTM: | 100000 |
| Diluted Eps TTM: | -3.43 |
Valuation
| Price Sales TTM: | 67.16 |
| Price Book MRQ: | 3.04 |
| Enterprise Value: | 488798176 |
| Enterprise Value Revenue: | 147.74 |
| Enterprise Value Ebitda: | -16.47 |
Shares
| Shares Outstanding: | 62917700 |
| Shares Float: | 26150128 |
| Percent Insiders: | 1.79 |
| Percent Institutions: | 50.22 |
Technicals
| Beta: | 1.45 |
| 52 Week High: | 15.42 |
| 52 Week Low: | 8.12 |
| 50 Day MA: | 9.89 |
| 200 Day MA: | 11.85 |
Earnings
| Report Date: | 2025-05-30 |
| Date: | 2025-03-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2025-03-31 |
| Date: | 2024-12-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2024-11-07 |
| Date: | 2024-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2023-11-29 |
| Date: | 2023-09-30 |
| Currency: | EUR |
| Eps Actual: | -0.58 |
| Eps Estimate: | -0.58 |
| Report Date: | 2023-09-21 |
| Date: | 2023-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.66 |
| Eps Difference: | -0.66 |
| Report Date: | 2023-04-19 |
| Date: | 2023-03-31 |
| Currency: | EUR |
| Eps Actual: | -2.39 |
| Eps Estimate: | -1.76 |
| Eps Difference: | -0.63 |
| Surprise Percent: | -35.79 |
| Report Date: | 2023-03-16 |
| Date: | 2022-12-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Estimate: | -1.76 |
| Eps Difference: | 1.76 |
| Surprise Percent: | 10 |
| Report Date: | 2022-11-30 |
| Date: | 2022-09-30 |
| Currency: | EUR |
| Report Date: | 2022-09-30 |
| Date: | 2022-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -1.77 |
| Report Date: | 2022-06-01 |
| Date: | 2022-03-31 |
| Currency: | EUR |
| Report Date: | 2022-03-16 |
| Date: | 2021-12-31 |
| Currency: | EUR |
| Eps Actual: | -1.7 |
| Eps Difference: | -1.7 |
| Report Date: | 2021-12-01 |
| Date: | 2021-09-30 |
| Currency: | EUR |
| Report Date: | 2021-09-23 |
| Date: | 2021-06-30 |
| Currency: | EUR |
| Eps Actual: | -1.13 |
| Eps Difference: | -1.13 |
| Report Date: | 2021-06-02 |
| Date: | 2021-03-31 |
| Currency: | EUR |
| Report Date: | 2021-03-31 |
| Date: | 2020-12-31 |
| Currency: | EUR |
| Eps Actual: | -1.82 |
| Eps Difference: | -1.82 |
| Report Date: | 2020-12-02 |
| Date: | 2020-09-30 |
| Currency: | EUR |
| Report Date: | 2020-09-24 |
| Date: | 2020-06-30 |
| Currency: | EUR |
| Eps Actual: | -1.26 |
| Eps Estimate: | -0.65 |
| Eps Difference: | -0.61 |
| Surprise Percent: | -93.84 |
| Report Date: | 2020-06-03 |
| Date: | 2020-03-31 |
| Currency: | EUR |
| Report Date: | 2020-03-16 |
| Date: | 2019-12-31 |
| Currency: | EUR |
| Eps Actual: | -1.17 |
| Eps Estimate: | -1.47 |
| Eps Difference: | 0.3 |
| Surprise Percent: | 20.40 |
| Report Date: | 2019-11-27 |
| Date: | 2019-09-30 |
| Currency: | EUR |
| Report Date: | 2019-09-19 |
| Date: | 2019-06-30 |
| Currency: | EUR |
| Eps Actual: | -1.38 |
| Eps Difference: | -1.38 |
| Report Date: | 2019-05-29 |
| Date: | 2019-03-31 |
| Currency: | EUR |
| Report Date: | 2019-03-14 |
| Date: | 2018-12-31 |
| Currency: | EUR |
| Eps Actual: | -1.6 |
| Eps Estimate: | -0.92 |
| Eps Difference: | -0.68 |
| Surprise Percent: | -73.91 |
| Report Date: | 2018-11-28 |
| Date: | 2018-09-30 |
| Currency: | EUR |
| Report Date: | 2018-09-28 |
| Date: | 2018-06-30 |
| Currency: | EUR |
| Eps Actual: | -0.72 |
| Eps Estimate: | -0.99 |
| Eps Difference: | 0.27 |
| Surprise Percent: | 27.27 |
| Report Date: | 2018-05-30 |
| Date: | 2018-03-31 |
| Currency: | EUR |
| Report Date: | 2018-03-16 |
| Date: | 2017-12-31 |
| Currency: | EUR |
| Eps Actual: | -0.57 |
| Eps Difference: | -0.57 |
| Report Date: | 2017-09-20 |
| Date: | 2017-06-30 |
| Currency: | EUR |
| Eps Actual: | -0.57 |
| Eps Estimate: | -0.86 |
| Eps Difference: | 0.29 |
| Surprise Percent: | 33.72 |
| Report Date: | 2017-05-12 |
| Date: | 2017-03-31 |
| Currency: | EUR |
| Eps Actual: | -0.63 |
| Eps Difference: | -0.63 |
| Report Date: | 2017-03-15 |
| Date: | 2016-12-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.63 |
| Eps Difference: | -0.63 |
| Report Date: | 2016-09-21 |
| Date: | 2016-06-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | -0.86 |
| Eps Difference: | -0.86 |
| Report Date: | 2016-04-28 |
| Date: | 2016-03-31 |
| Currency: | EUR |
| Eps Actual: | -0.91 |
| Eps Difference: | -0.91 |
| Date: | 2016-12-31 |
| Period: | +1y |
| Revenue Estimate Low: | 28190000.00 |
| Revenue Estimate High: | 28190000.00 |
| Revenue Estimate Number Of Analysts: | 1.00 |
| Eps Trend7days Ago: | -1.47 |
| Eps Trend30days Ago: | -1.47 |
| Eps Trend60days Ago: | -1.47 |
| Eps Trend90days Ago: | -1.47 |
| Date: | 2015-12-31 |
| Revenue Estimate Avg: | 228000.00 |
| Revenue Estimate Low: | 60000.00 |
| Revenue Estimate High: | 2460000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Eps Trend7days Ago: | -1.74 |
| Eps Trend30days Ago: | -1.74 |
| Eps Trend60days Ago: | -1.74 |
| Eps Trend90days Ago: | -1.74 |
| Date: | 2015-09-30 |
| Period: | +1q |
| Revenue Estimate Avg: | 2424000.00 |
| Revenue Estimate Low: | 2700000.00 |
| Revenue Estimate High: | 2700000.00 |
| Revenue Estimate Number Of Analysts: | 1.00 |
| Eps Trend7days Ago: | -0.45 |
| Eps Trend30days Ago: | -0.45 |
| Eps Trend60days Ago: | -0.45 |
| Eps Trend90days Ago: | -0.45 |
| Date: | 2015-06-30 |
| Revenue Estimate Low: | 2200000.00 |
| Revenue Estimate High: | 2200000.00 |
| Revenue Estimate Number Of Analysts: | 1.00 |
| Eps Trend7days Ago: | -0.32 |
| Eps Trend30days Ago: | -0.32 |
| Eps Trend60days Ago: | -0.32 |
| Eps Trend90days Ago: | -0.32 |
| Date: | 2024-09-30 |
| Eps Actual: | -3.64 |
| Date: | 2022-12-31 |
| Eps Actual: | -1.7 |
| Date: | 2021-12-31 |
| Eps Actual: | -2.8 |
| Date: | 2020-12-31 |
| Eps Actual: | -3.0 |
| Date: | 2019-12-31 |
| Eps Actual: | -2.5 |
| Date: | 2018-12-31 |
| Eps Actual: | -2.3 |
| Date: | 2017-12-31 |
| Eps Actual: | -1.7 |
| Date: | 2016-12-31 |
| Eps Actual: | -2. |